GLP-1 Medications Explained: The Science of Appetite and Weight Loss

GLP-1 is something your body already makes

GLP-1 (glucagon-like peptide-1) is a natural hormone released by your gut, mostly from the lower small intestine, within minutes of you starting to eat. It is part of the conversation your digestive system has with your brain, and it carries three main messages:

• "You are full." GLP-1 acts on appetite centres in the brain to bring on the feeling of satisfaction that tells you to stop eating.
• "Slow down." It slows how quickly your stomach empties, so food stays with you longer and hunger takes longer to return.
• "Manage the sugar." It nudges the pancreas to release insulin when blood sugar is high, helping keep your levels steady after a meal.

In other words, GLP-1 is one of the body's own tools for feeling satisfied. The catch is that the natural version is broken down within a couple of minutes, so its effect is brief.

What GLP-1 medications actually do

This is the clever part. GLP-1 receptor agonist medicines are engineered to switch on the same receptors as your natural hormone, but at higher levels and, crucially, for far longer. Instead of a signal that lasts minutes, a modern medicine can keep that "you are full" message running for a whole week from a single dose.

The result is not a stimulant, and it is not a fat burner. It is the same satiety signal you already produce, simply turned up and held there. That is why the everyday experience of taking one is less about forcing willpower and more about hunger quietly stepping back.

Quietening the "food noise"

If you have ever spent an afternoon half-thinking about the biscuits in the cupboard, you have met food noise: the constant background chatter about snacks, second helpings and what is for dinner. Many people on GLP-1 medicines describe the same striking change, that this noise simply gets quieter.

That single shift explains a lot. When food stops occupying mental space, smaller portions feel normal rather than like deprivation, and the daily grind of dieting eases. We go deeper into this mechanism in our guide to how Mounjaro works.

The landscape: who is who

The category has grown quickly, so here is an honest, plain map of the main players. All of these are prescription-only medicines.

• Semaglutide is the active ingredient in Ozempic, which is licensed for type 2 diabetes, and in Wegovy, which is licensed for weight management. Same molecule, different brand and dosing depending on its approved use. Semaglutide acts on the GLP-1 receptor alone.
• Tirzepatide is the active ingredient in Mounjaro. It is a dual agonist, meaning it acts on two receptors: GLP-1 and a second gut hormone called GIP (glucose-dependent insulinotropic polypeptide).
• Liraglutide is an earlier GLP-1 medicine (brand names include Saxenda and Victoza). It works on the same principle but is taken as a daily rather than weekly injection.

If you want a side-by-side view of the most talked-about options, our comparison of Mounjaro vs Ozempic vs Wegovy lays out the differences without the hype.

Picture appetite as a thermostat set too high. GLP-1 medicines quietly turn it down.

Why two hormones can beat one

You might reasonably ask why tirzepatide, the dual medicine, tends to outperform the GLP-1-only options on average. The short answer is that it recruits a second pathway.

By acting on both GLP-1 and GIP, tirzepatide engages two complementary systems involved in appetite and blood sugar rather than one. In practice, clinical research has found that this dual action produces larger average weight loss than single-receptor medicines. It is worth being precise here: "on average" does real work in that sentence, because individual results vary widely with dose, starting weight, diet and activity.

Who these medicines are for

GLP-1 medicines are powerful, and that is exactly why they are not handed out casually. Broadly, they are considered for:

• adults living with obesity, or with excess weight plus a related condition such as high blood pressure or raised blood sugar, and
• adults with type 2 diabetes, where several of these medicines were first established.

Whether any of this applies to you is a clinical decision, not a self-diagnosis. A prescriber reviews your health history, your BMI and the other medicines you take before deciding if a GLP-1 medicine is appropriate and safe. They are not suitable for everyone, and they are not used during pregnancy.

Curious whether a medical weight-loss programme could be right for you? A regulated pharmacy consultation checks your eligibility and, if appropriate, sets up a prescription with a proper dose plan and follow-up.

The honest part: they are a tool, not a cure

Two things are worth saying plainly, because the marketing rarely does.

First, these medicines work best alongside good nutrition and regular activity. The trials that produced the eye-catching numbers all paired the medicine with lifestyle changes. Reducing appetite is a huge advantage, but what you do eat still matters, especially getting enough protein so you lose fat rather than muscle. Our guide to what to eat covers how to do this well when your appetite has dropped.

Second, the effect depends on the medicine being present. GLP-1 medicines lower your appetite set-point while you take them. If you stop, that set-point tends to drift back up, appetite returns, and studies show some of the lost weight is usually regained. This is biology, not a personal failing, and it is why clinicians treat these as long-term tools and use the appetite window to help rebuild lasting habits.

The takeaway

GLP-1 medications are not magic and they are not a gimmick. They are a precise piece of biology: your own fullness hormone, borrowed, strengthened and made to last. Used under proper medical care and paired with sensible eating and movement, they can make weight loss feel possible for people who have found it impossible before. The starting point is always a proper conversation with a clinician who can tell you, honestly, whether one is right for you.